secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTERPACE BIOSCIENCES, INC. (IDXG)
CIK:        0001054102
Form:       8-K
Filed at:   2021-10-01T23:59:59+00:00
Accession:  0001493152-21-024381
Event type: debt
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Interpace Biosciences extends maturity of $7.5M in secured notes to October 31, 2021
--------------------------------------------------------------------------------

- Ampersand Note principal $4.5M, 1315 Capital Note $3.0M; total $7.5M in secured debt.
- Maturity date extended one month from September 30, 2021 to October 31, 2021.
- This is the fourth amendment to each note; terms otherwise unchanged.
- Security agreement remains in full force and effect.
- Noteholders are related parties holding convertible preferred shares (39% and 26% fully diluted combined).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1054102/000149315221024381/0001493152-21-024381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1054102/000149315221024381/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-024381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer